22:45 , Nov 30, 2017 |  BC Extra  |  Company News

Management Tracks:Sunesis, City of Hope

Cancer company Sunesis Pharmaceuticals Inc. (NASDAQ:SNSS) hired William Quinn as CFO and SVP of finance and corporate development. He was president and CEO of Bullet Biotechnology Inc. (Redwood City, Calif.), which he co-founded. City of...
07:00 , May 25, 2015 |  BC Week In Review  |  Clinical News

Pembrolizumab: Phase II started

Cancer Treatment Centers of America began the Phase II portion of the open-label, U.S. Phase Ib/II PembroPlus trial to evaluate 2 mg/kg IV Keytruda from Merck every 3 weeks in combination with gemcitabine, docetaxel, Abraxane...
07:00 , Jul 16, 2012 |  BC Week In Review  |  Company News

Merrimack, Cancer Treatment Centers of America deal

Merrimack received non-exclusive access to the centers' archived and prospectively collected tumor biopsies. Merrimack will analyze the samples using its Network Biology approach to identify network signaling that drives cancer growth. Merrimack said the collaboration...